Search results
Results from the WOW.Com Content Network
Collaborative Drug Discovery (CDD) is a software company founded in 2004 as a spin-out of Eli Lilly by Barry Bunin, PhD. CDD utilizes a web-based database solution for managing drug discovery data, primarily through the CDD Vault product which is focused around small molecules and associated bio-assay data.
In addition to internal research and development activities J&JPRD is also involved in publicly funded collaborative research projects, with other industrial and academic partners. One example in the area of non-clinical safety assessment is the InnoMed PredTox.
During Eli's 16-year presidency, sales rose from $13 million in 1932 to $117 million in 1948. Joe joined the company in 1914 and concentrated on the company's personnel and marketing efforts. [39] He served as company president from 1948 to 1953, then became chairman of the board, and remained in that capacity until his death in 1966. [76]
Quantum Leap Healthcare Collaborative-sponsored I-SPY COVID Trial will not further test Aerpio Pharmaceuticals Inc's (NASDAQ: ARPO) razuprotafib. Razuprotafib was chosen because it was believed to ...
The company was formed in a collaboration between pharmaceuticals company Pfizer and private equity firm Bain Capital. [ 3 ] [ 4 ] In 2019, Cerevel appointed N. Anthony Coles as its chief executive officer. [ 5 ]
Co-promotion plays a major role in the pharmaceutical industries because in today's market, pharma companies are in a situation of falling productivity. [8] Accessing to new products through association with biotech companies allows pharma companies to expand their influence and guarantee their success over the market.
Major pharmaceutical companies such as Pfizer [17] and Bristol-Myers Squibb have arranged clinical collaborations with companies such as NeoImmuneTech, [18] Checkmate Pharmaceuticals and Kitov [19] for testing and evaluating the effectiveness of combinations of existing medicines. If the tested combination attains regulatory approval, "it opens ...
Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. [1] [2] [3] The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson. [4] [5]